IP Library Granted Patent US 12,145,960
Granted Patent B2
US 12,145,960 · App. 17/287,255 · Granted Nov 19, 2024

Nucleotide analogues

Inventors: Ronald Graham (Carlsbad, CA); Olga Adelfinskaya (San Marcos, CA); Megha Cila (San Diego, CA); Rodrigo Rodriguez (San Diego, CA); Abrehet Abdu (San Diego, CA); Eli N. Glezer (Del Mar, CA)
Assignee: Singular Genomics Systems, Inc.
C07H19/14C07H19/10C07H19/20C12Q1/6869C12Q1/6876
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,145,960
App. No.
17/287,255
Filed
Apr 21, 2021
Granted
Nov 19, 2024
Kind
B2
Examiner
RILEY, JEZIA
Art Unit
1681
USPC
435/6.12
Abstract

Disclosed herein, interalia, are compounds, compositions, and methods of using the same for the sequencing of a nucleic acid.

Claims (37)

1. A compound having the formula:

wherein,

B P is a nucleobase;

R 1P is hydrogen, or 5′-nucleoside protecting group, or —OR 1P is a monophosphate, or polyphosphate;

R 3P is hydrogen or —OR 3AP ; wherein R 3AP is hydrogen or a polymerase-compatible cleavable moiety;

L 1P is a substituted methylene, wherein L 1P is substituted with a haloalkyl, or substituted or unsubstituted heteroalkyl; and

R 6P is unsubstituted alkyl.

2. The compound of claim 1 , wherein R 3P is hydrogen or —OH.

3. The compound of claim 1 , wherein R 1P is hydrogen.

4. The compound of claim 1 , wherein OR 1P is a monophosphate moiety or polyphosphate moiety.

5. The compound of claim 1 , wherein B P is a monovalent cytosine or a derivative thereof, monovalent guanine or a derivative thereof, monovalent adenine or a derivative thereof, monovalent thymine or a derivative thereof, monovalent uracil or a derivative thereof, monovalent hypoxanthine or a derivative thereof, monovalent xanthine or a derivative thereof, monovalent 7-methylguanine or a derivative thereof, monovalent 5,6-dihydrouracil or a derivative thereof, monovalent 5-methylcytosine or a derivative thereof, or monovalent 5-hydroxymethylcytosine or a derivative thereof.

6. The compound of claim 1 , wherein B P is

7. The compound of claim 1 , wherein

B P is optionally substituted adenine, optionally substituted guanine, optionally substituted uracil, optionally substituted cytosine, optionally substituted thymine, optionally substituted hypoxanthine, optionally substituted xanthine, optionally substituted theobromine, optionally substituted caffeine, optionally substituted uric acid, or optionally substituted isoguanine.

8. The compound of claim 7 , wherein B P further comprises a fluorophore.

9. A method for sequencing a nucleic acid, comprising:

(i) incorporating in series with a nucleic acid polymerase, within a reaction vessel, one of four different compounds into a primer to create an extension strand, wherein said primer is hybridized to said nucleic acid and wherein each of the four different compounds comprises a unique detectable label;

(ii) detecting said unique detectable label of each incorporated compound, so as to thereby identify each incorporated compound in said extension strand, thereby sequencing the nucleic acid;

wherein each of said four different compounds is independently a compound of claim 1 .

10. A method of incorporating a compound into a primer, the method comprising combining a polymerase, a primer hybridized to nucleic acid template and the compound within a reaction vessel and allowing said polymerase to incorporate said compound into said primer thereby forming an extended primer, wherein said compound is a compound of claim 1 .

11. A compound having the formula:

wherein,

B P is a nucleobase;

R 1P is hydrogen, or 5′-nucleoside protecting group, or —OR 1P is a monophosphate, or polyphosphate;

R 3P is hydrogen or —OR 3AP ; wherein R 3AP is hydrogen or a polymerase-compatible cleavable moiety;

L 1P is a substituted methylene, wherein L 1P is substituted with substituted or unsubstituted alkyl, or substituted or unsubstituted heteroalkyl; and

R 6P is unsubstituted C 2 alkyl.

12. A method for sequencing a nucleic acid, comprising:

(i) incorporating in series with a nucleic acid polymerase, within a reaction vessel, one of four different compounds into a primer to create an extension strand, wherein said primer is hybridized to said nucleic acid and wherein each of the four different compounds comprises a unique detectable label;

(ii) detecting said unique detectable label of each incorporated compound, so as to thereby identify each incorporated compound in said extension strand, thereby sequencing the nucleic acid;

wherein each of said four different compounds is independently a compound of claim 11 .

13. A method of incorporating a compound into a primer, the method comprising combining a polymerase, a primer hybridized to nucleic acid template and the compound within a reaction vessel and allowing said polymerase to incorporate said compound into said primer thereby forming an extended primer, wherein said compound is a compound of claim 11 .

14. The compound of claim 1 , wherein -L 1P -S—S—R 6P is:

15. The compound of claim 11 , wherein L 1P is substituted with unsubstituted alkyl or unsubstituted heteroalkyl.

16. The compound of claim 11 , wherein L 1P is substituted with unsubstituted alkyl.

17. The compound of claim 11 , wherein B P further comprises a fluorophore.

18. The compound of claim 11 , wherein -L 1P S—S—R 6P is:

Assignments (1)
SECURITY INTEREST Recorded Mar 7, 2025
From: SINGULAR GENOMICS SYSTEMS, INC.
To: FIRST-CITIZENS BANK & TRUST COMPANY
Reel/Frame 070440/0465 →
Continuity (4)
Provisional Application 62841146 · Apr 30, 2019
Provisional Application 62789877 · Jan 8, 2019
Provisional Application 62750552 · Oct 25, 2018
Related Publication 20230028359A1 · Jan 26, 2023
Cited By (2)
US 12,577,271 US 12,595,508